🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
This study will evaluate the safety and immunogenicity in healthy children ...
Status
Completed
Location
Centro de Atención e Investigación Medica - CAIMED
Start Date
2010-09
Trial ID
NCT01209780
Treatments Being Tested
The purpose of this study is to evaluate the clinical performance supportin...
Status
Completed
Location
Cerba Xpert
Start Date
2024-02-27
Trial ID
NCT06289868
The purpose of this study is to evaluate the safety and immunogenicity of c...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00264576
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-25
Trial ID
NCT02184572
Treatments Being Tested
Background: Malaria is a disease that affects many people in Africa. It is...
Status
Suspended
Location
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, Health Research Center
Start Date
2026-09-02
Trial ID
NCT05652504
Treatments Being Tested
This study will evaluate the lot to lot consistency, safety and immune resp...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00450437
Treatments Being Tested
This study will evaluate the safety and immune response to GlaxoSmithKline ...
Status
Completed
Location
GSK Investigational Site
Start Date
2002-11
Trial ID
NCT00109330
Treatments Being Tested
A total of 18,000 eligible subjects (or 6,000 subject distributed evenly be...
Status
Active Not Recruiting
Location
Naval Medical Center San Diego
Start Date
2018-11-06
Trial ID
NCT03734237
The purpose of this research is to demonstrate immunologic equivalence of t...
Status
Completed
Location
Centro de Salud Galvan
Start Date
2007-11
Trial ID
NCT00617851